Back to
CITADEL ADVISORS LLC
SUPN29 quarters
Position history for
CITADEL ADVISORS LLC's holdings in SUPERNUS PHARMACEUTICALS
CITADEL ADVISORS LLC holds 1.5M shares of SUPN (SUPERNUS PHARMACEUTICALS), worth $77.2M as of 2026-Q1. The position was increased (+229.7% shares). SUPN represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$77.2M
Current Shares
1.5M
Total Value Change
+$74.7M
Total Shares Change
+1.4M
Quarter-by-Quarter History
Other major holders of SUPN: BlackRock, Inc., BlackRock Finance, Inc.